Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

GILD

Showing 8 of 27 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in Gilead Sciences, Inc.

Yes. Ensign Peak Advisors holds 1,940,617 shares of GILD (Gilead Sciences), worth $245.2M, as of its Q2 2026 13F filing. It reduced the position by 397,605 shares (-17.0%) from Q1 2026. Ensign Peak Advisors has held GILD in every 13F on record since Q4 2019, 27 quarterly filings. GILD is 0.4% of Ensign Peak Advisors' reported 13F portfolio.

Current Value

$245.2M

Current Shares

1.9M

Total Value Change

+$110.2M

Total Shares Change

+331,220

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.9M
-17.0%
$245.2M0.4%$125.63
0
2026-Q1
Increased
2.3M
+20.8%
$325.9M0.6%$137.68
52
2025-Q4
Decreased
1.9M
-27.1%
$237.7M0.4%$120.57
0
2025-Q3
Increased
2.7M
+15.7%
$295M0.5%$108.32
43
2025-Q2
Increased
2.3M
+7.1%
$254.7M0.4%$107.45
39
2025-Q1
Increased
2.1M
+28.4%
$240.3M0.5%$107.83
46
2024-Q4
Increased
1.7M
+3.8%
$154.2M0.3%$88.27
38
2024-Q3
Increased
1.6M
+12.6%
$134.9M0.2%$79.45
41

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used